Pub. Date : 2008 Nov
PMID : 18682265
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Considering that PMA prevents the inhibitory effect of Ado on Ang II-stimulated Na(+)-ATPase and PKC activities, it is likely that the PMA-induced effect, i.e. PKC activation, is downstream of the target for Ado-induced reversion of Ang II stimulation of Na(+)-ATPase activity. | Tetradecanoylphorbol Acetate | angiotensinogen | Homo sapiens |
2 | Considering that PMA prevents the inhibitory effect of Ado on Ang II-stimulated Na(+)-ATPase and PKC activities, it is likely that the PMA-induced effect, i.e. PKC activation, is downstream of the target for Ado-induced reversion of Ang II stimulation of Na(+)-ATPase activity. | Tetradecanoylphorbol Acetate | angiotensinogen | Homo sapiens |
3 | Considering that PMA prevents the inhibitory effect of Ado on Ang II-stimulated Na(+)-ATPase and PKC activities, it is likely that the PMA-induced effect, i.e. PKC activation, is downstream of the target for Ado-induced reversion of Ang II stimulation of Na(+)-ATPase activity. | Tetradecanoylphorbol Acetate | angiotensinogen | Homo sapiens |
4 | Considering that PMA prevents the inhibitory effect of Ado on Ang II-stimulated Na(+)-ATPase and PKC activities, it is likely that the PMA-induced effect, i.e. PKC activation, is downstream of the target for Ado-induced reversion of Ang II stimulation of Na(+)-ATPase activity. | Tetradecanoylphorbol Acetate | angiotensinogen | Homo sapiens |